Igor Feldman

Igor Feldman

Company: Verseau Therapeutics

Job title: Co-Founder, Vice President & Head of Computational Biology


Igor Feldman is a Co-Founder and has served as a Vice President and the Head of Computational Biology at Verseau Therapeutics since January 2017. Igor has held positions at Merck & Co., Rosetta Informatics, Jounce Therapeutics and Epizyme. He has been involved in discovery and clinical development using large omics datasets of human tumors, drug response biomarker discovery, novel target discovery in immuno-oncology and epigenetics and establishing computational infrastructure from the ground up for early discovery and development support in several biotech startup companies. He is an inventor on eight U.S. patents. Igor holds a B.S. in biology and a Ph.D. in systems biology from Columbia University.


Testing Tumor-associated Macrophage Repolarization to Induce an Immune Response using Human Ex Vivo Tumor Cultures 1:00 pm - 4:00 pm

Join this workshop to: • Understand motivation for developing ex vivo cultures to test macrophage-based therapies against human cancers • Compare the advantages and disadvantages between tumor slice and tumor dissociated cultures • Review Keytruda and macrophage-repolarizing agents’ response across multiple tumor types • Leave understanding the implications of using human ex vivo tumor cultures…Read more

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.